LGT Fund Management’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$268K Sell
1,628
-833
-34% -$144K 0.01% 232
2025
Q4
$441K Sell
2,461
-867
-26% -$145K 0.03% 182
2025
Q3
$522K Sell
3,328
-510
-13% -$75.3K 0.04% 176
2025
Q2
$541K Sell
3,838
-4,161
-52% -$511K 0.05% 182
2025
Q1
$933K Buy
7,999
+785
+11% +$101K 0.08% 152
2024
Q4
$907K Sell
7,214
-933
-11% -$115K 0.08% 165
2024
Q3
$852K Buy
8,147
+205
+3% +$20.6K 0.09% 135
2024
Q2
$772K Buy
+7,942
New +$756K 0.1% 125
2023
Q4
Sell
-15,090
Closed -$1.21M 117
2023
Q3
$1.21M Buy
15,090
+1,200
+9% +$104K 0.59% 66
2023
Q2
$1.19M Sell
13,890
-3,250
-19% -$278K 0.55% 65
2023
Q1
$1.5M Buy
+17,140
New +$1.6M 0.64% 62
2022
Q3
Sell
-37,000
Closed -$2.81M 160
2022
Q2
$2.81M Sell
37,000
-10,000
-21% -$819K 0.41% 71
2022
Q1
$4.09M Sell
47,000
-46,000
-49% -$4.44M 0.54% 48
2021
Q4
$9.13M Buy
+93,000
New +$9.26M 2.63% 7

Other funds holding MS

LGT Fund Management's MS Position: Q1 2026 in Review

LGT Fund Management reduced its Morgan Stanley (MS) stake by 34% in Q1 2026, selling an estimated $144K and leaving 1,628 shares worth $268K. The position accounts for 0.01% of the portfolio, ranked #232.

LGT Fund Management first reported a position in MS in Q4 2021 and has held it in 14 quarters since. The position peaked at $9.13M in Q4 2021. 2,490 funds tracked by Wall St. Rank hold MS as of Q1 2026.

  • LGT Fund Management held 1,628 shares of Morgan Stanley worth $268K as of Q1 2026.
  • LGT Fund Management sold 833 Morgan Stanley shares in Q1 2026, an estimated $144K.
  • Morgan Stanley made up 0.01% of LGT Fund Management's portfolio in Q1 2026, its #232 holding.
  • LGT Fund Management first reported a position in Morgan Stanley in Q4 2021 and has held it in 14 quarters since.
  • LGT Fund Management's Morgan Stanley position peaked at $9.13M in Q4 2021.
  • 2,490 funds tracked by Wall St. Rank held Morgan Stanley as of Q1 2026.

Based on LGT Fund Management's 13F filing for Q1 2026, filed 28 Apr 2026.